Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

NuVasive, Inc. Focused On Surgeon Support And Showcasing Industry-Leading Products At North American Spine Society 29th Annual Meeting

November 12, 2014 – 5:00 am | Edit Post

SAN DIEGO, CA–(Marketwired – November 10, 2014) – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it will attend the 29th North American Spine Society (“NASS…

Isis Pharmaceuticals, Inc. Prices Offering Of $425 Million Of 1.00% Convertible Senior Notes

November 12, 2014 – 5:00 am | Edit Post

CARLSBAD, Calif., Nov. 12, 2014 /PRNewswire/ –Isis Pharmaceuticals,Inc. (NASDAQ: ISIS) announced today the pricing of its offering of $425.0 million aggregate principal amount of Convertible Senior Notes due 2021 (the “Convertible Notes”) in a private placement. Isis also granted…

Sorrento Therapeutics, Inc. To Present At The 2014 Healthcare Conference

November 12, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 /PRNewswire/ –Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), today announced that Dr. Henry Ji, President and Chief Executive Officer, will present on Tuesday, November 18, 2014 at 3:00 pm…

Biocept, Inc. Launches Lung Cancer Offering

November 12, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) — Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA and Circulating Tumor Cells (CTCs), today announced the launch of its lung cancer liquid biopsy testing that will be performed…

Celladon Corporation Reports Third Quarter 2014 Financial Results And Recent Highlights

November 12, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) — Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced financial results for the quarter ended September 30, 2014 and recent corporate highlights…

Tandem Diabetes Care Expands Diabetes Data Management Access With Partnership

November 12, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 /PRNewswire/ — Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim Insulin Pump, announced today that the t:slim Pump is now compatible with diasend Clinic, a web-based diabetes data management tool developed by Diasend. Healthcare providers…

MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) To Present At Healthcare Conference

November 12, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 /PRNewswire/ — MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the Stifel Healthcare…

Batu Biologics Recruits Inventor Of Licensed University of California, San Diego (UCSD) Cancer Immunotherapy To Scientific Advisory Board

November 12, 2014 – 5:00 am | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Batu Biologics, an immunotherapy company developing the ValloVax anti-angiogenic lung cancer vaccine, announced today the addition Dr. Davorka Messmer to its Scientific Advisory Board (SAB).Dr. Messmer will accelerate the clinical development of the companys cancer vaccine platform, which trains the immune system to selectively destroy the tumor-associated…

TrovaGene, Inc. To Present At Upcoming Healthcare Conferences

November 12, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 /PRNewswire/ –Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that Chief Executive Officer Antonius Schuh, Ph.D., is scheduled to present a corporate overview at the following 2014 healthcare conferences: the Stifel 2014 Healthcare Conference…

Batu Biologics Recruits Inventor Of Licensed University of California, San Diego (UCSD) Cancer Immunotherapy To Scientific Advisory Board

November 12, 2014 – 5:00 am | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Batu Biologics, an immunotherapy company developing the ValloVax anti-angiogenic lung cancer vaccine, announced today the addition Dr. Davorka Messmer to its Scientific Advisory Board (SAB).Dr. Messmer will accelerate the clinical development of the companys cancer vaccine platform, which trains the immune system to selectively destroy the tumor-associated…